Learn More
Apexbio Technology LLC SR 202 76541-72-5 10mg

Supplier: Apexbio Technology LLC B692910
SR 202 (CAS 76541-72-5) is a small-molecule antagonist targeting peroxisome proliferator-activated receptor gamma (PPAR ) It is designed to selectively suppress PPAR -mediated transcriptional activity thereby regulating adipogenesis and glucose homeostasis pathways SR 202 exerts its biological activity primarily by inhibiting thiazolidinedione-induced recruitment of coactivators to PPAR and attenuating ligand-dependent adipocyte differentiation In vitro studies demonstrate that SR 202 reduces PPAR -driven adipogenic processes and inhibits thiazolidinedione-induced transcriptional activation with an IC50 of 140 M Based on these pharmacological properties SR 202 holds research potential in the study of obesity insulin resistance and type 2 diabetes
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.